DAPAVEL L 10/5MG (Dapagliflozin (10mg) + Linagliptin (5mg))

Dapavel-L 10/5 Tablet is a medicinal product that combines two active ingredients aimed at regulating blood glucose levels in individuals diagnosed with type 2 diabetes mellitus. When utilized as part of a comprehensive management plan that includes a balanced diet and regular physical activity, this medication can significantly enhance glycemic control and reduce the risk of severe diabetes-related complications. It is advisable to take this medication consistently, either with or without meals, at the same time each day to promote adherence. The prescribing physician will determine the appropriate dosage and duration of treatment based on individual patient needs. Patients should not discontinue use without consulting their healthcare provider, as doing so may lead to uncontrolled blood sugar levels and increase the likelihood of severe complications such as renal impairment and vision loss. This medication complements lifestyle modifications that are essential for effective diabetes management, including nutritional guidance, physical activity, and weight management based on medical advice. Notably, potential adverse effects may include vaginal yeast infections, nasopharyngitis, urinary tract infections, instances of hypoglycemia, dizziness, and feelings of weakness. Patients experiencing persistent or worsening symptoms should inform their doctor. Good hygiene practices may assist in preventing fungal infections in sensitive areas. Prior to commencing treatment, individuals should disclose any existing kidney or liver conditions, urinary tract infections, or use of diuretics to their healthcare provider. Pregnant and breastfeeding women are advised to seek medical counsel before initiating therapy. Regular monitoring of blood glucose levels is strongly recommended while under treatment.